Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | -4.67% | -7.27% | -17.74% |
May. 09 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.74% | 216M | |
+8.38% | 114B | |
+10.13% | 104B | |
-11.69% | 22.5B | |
+1.31% | 22.57B | |
-11.11% | 17.95B | |
-41.90% | 16.48B | |
-16.00% | 15.82B | |
+2.28% | 13.55B | |
+20.54% | 10.99B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- HC Wainwright Downgrades Akebia Therapeutics to Neutral From Buy, Adjusts Price Target to $2 From $10